Achieve Life Sciences Inc (ACHV)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.36 -0.04 (-1.67%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.36 unch (unch) 16:02 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,827 | -29,815 | -42,350 | -33,152 | -14,730 |
| Depreciation Amortization | 252 | 228 | 236 | 250 | 255 |
| Accounts receivable | 111 | -6 | 48 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,332 | -1,042 | 799 | 509 | -527 |
| Other Working Capital | 2,412 | -778 | 79 | 1,387 | -285 |
| Other Operating Activity | 5,950 | 6,934 | 3,619 | 1,566 | 1,813 |
| Operating Cash Flow | $-29,770 | $-24,479 | $-37,569 | $-29,440 | $-13,474 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,580 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | -21 | N/A | N/A | -17 |
| Investing Cash Flow | $-21,580 | $-21 | $N/A | $N/A | $-17 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,330 | N/A | N/A |
| Debt Repayment | -18,109 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 860 | 197 | 18,032 | 338 | 3,231 |
| Other Financing Activity | 65,776 | 15,081 | -47 | 36,272 | 29,449 |
| Financing Cash Flow | $48,527 | $15,278 | $19,315 | $36,610 | $32,680 |
| Exchange Rate Effect | N/A | -3 | 3 | -1 | N/A |
| Beginning Cash Position | 15,596 | 24,821 | 43,072 | 35,903 | 16,714 |
| End Cash Position | 12,773 | 15,596 | 24,821 | 43,072 | 35,903 |
| Net Cash Flow | $-2,823 | $-9,225 | $-18,251 | $7,169 | $19,189 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,770 | -24,479 | -37,569 | -29,440 | -13,474 |
| Capital Expenditure | N/A | -21 | N/A | N/A | -17 |
| Free Cash Flow | -29,770 | -24,500 | -37,569 | -29,440 | -13,491 |